XML 232 R27.htm IDEA: XBRL DOCUMENT
v3.24.1.1.u2

Fair Value Measurements | 12 Months Ended
--- | ---
Mar. 31, 2024
Fair Value Disclosures [Abstract] |
Fair Value Measurements | Fair Value Measurements The financial instruments measured at fair value on a recurring basis in the accompanying consolidated balance sheets consist of the following:
| Recurring Fair Value Measurements as of March 31, 2024
| Level 1 |  | Level 2 |  | Level 3 |  | Total
Assets: |  |  |  |  |  |  |
Current derivative instruments (1) | $ | — |  |  | $ | 8,713 |  |  | $ | — |  |  | $ | 8,713 |
Long-term derivative instruments (1) | — |  |  | 1,556 |  |  | — |  |  | 1,556 |
Long term deferred compensation plan asset (2) | 28,957 |  |  | — |  |  | — |  |  | 28,957 |
Total Assets | $ | 28,957 |  |  | $ | 10,269 |  |  | $ | — |  |  | $ | 39,226 |
Liabilities: |  |  |  |  |  |  |
Long term deferred compensation plan liability (2) | 28,957 |  |  | — |  |  | — |  |  | 28,957 |
Total Liabilities | $ | 28,957 |  |  | $ | — |  |  | $ | — |  |  | $ | 28,957 |
| Recurring Fair Value Measurements as of March 31, 2023
| Level 1 |  | Level 2 |  | Level 3 |  | Total
Assets: |  |  |  |  |  |  |
Current derivative instruments (1) | $ | — |  |  | $ | 11,245 |  |  | $ | — |  |  | $ | 11,245 |
Long-term derivative instruments (1) | — |  |  | 3,530 |  |  | — |  |  | 3,530 |
Long term deferred compensation plan asset (2) | $ | 20,090 |  |  | $ | — |  |  | $ | — |  |  | $ | 20,090 |
Total Assets | $ | 20,090 |  |  | $ | 14,775 |  |  | $ | — |  |  | $ | 34,865 |
Liabilities: |  |  |  |  |  |  |
Long-term derivative instruments (1) | — |  |  | 1,369 |  |  | — |  |  | 1,369 |
Long term deferred compensation plan liability (2) | 20,090 |  |  | — |  |  | — |  |  | 20,090 |
Total liabilities | $ | 20,090 |  |  | $ | 1,369 |  |  | $ | — |  |  | $ | 21,459 |
(1) The Company’s interest rate swaps are considered over-the-counter derivatives and fair value is estimated based on the present value of future cash flows using a model-derived valuation that uses Level 2 observable inputs such as interest rate yield curves. See Note 11, “Derivatives,” to the consolidated financial statements for further discussion on the Company’s derivative instruments designated as cash flow hedges. (2) Investments in this category consist primarily of mutual funds whose fair values are determined by reference to the quoted market price per unit in active markets multiplied by the number of units held without consideration of transaction costs. These assets represent investments held in a consolidated trust to fund the Company's non-qualified deferred compensation plan and are recorded in other long-term assets and other long-term liabilities on our consolidated balance sheets. The fair value of the Company's cash and cash equivalents, which are Level 1 inputs, approximated its carrying values at March 31, 2024 and 2023. The Company’s cash and cash equivalent balances presented on the accompanying consolidated balance sheets include $192.7 million and $237.8 million of marketable securities in money market funds as of March 31, 2024 and 2023, respectively. The Company's long-term debt is carried at amortized cost and is measured at fair value quarterly for disclosure purposes. The estimated fair values of debt are determined using quoted prices or other market information obtained from recent trading activity of the debt in markets that are not active (Level 2 inputs). The fair value is corroborated by prices derived from the interest rate spreads of recently completed leveraged loan transactions of a similar credit profile, industry, and terms to that of the Company. The fair value of the Senior Notes are determined using quoted prices or other market information obtained from recent trading activity in the high-yield bond market (Level 2 inputs). The carrying amount and estimated fair value of debt consists of the following:
| March 31, 2024 |  | March 31, 2023
| Carrying Amount |  | Estimated Fair Value |  | Carrying Amount |  | Estimated Fair Value
Term Loan A | $ | 1,588,125 |  |  | $ | 1,582,170 |  |  | $ | 1,629,375 |  |  | $ | 1,600,861 |
3.875% Senior Notes due 2028 | 700,000 |  |  | 656,677 |  |  | 700,000 |  |  | 638,540 |
4.000% Senior Notes due 2029 | 500,000 |  |  | 465,470 |  |  | 500,000 |  |  | 451,930 |
5.950% Senior Notes due 2033 | 650,000 |  |  | 672,815 |  |  | — |  |  | — |
For our investments that are measured at fair value on a non-recurring basis, we did not have any material measurement adjustments during fiscal 2024. See Note 5, “Acquisition and Divestitures,” to the consolidated financial statements for details on non-recurring fair value measurement adjustments related to the assets and liabilities acquired through our acquisitions.

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_FairValueDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration